[시장보고서]생식 유전학 시장 보고서 : 제품 유형별, 처치 유형별, 기술별, 용도별, 지역별(2026-2034년)

생식 유전학 시장 보고서 : 제품 유형별, 처치 유형별, 기술별, 용도별, 지역별(2026-2034년)

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2026-2034

상품코드 : 1941220

리서치사 : IMARC

발행일 : 2026년 02월

페이지 정보 : 영문 139 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,999

￦ 6,036,000

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.

US $ 4,999

￦ 7,545,000

PDF & Excel (5 User License)

PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,999

￦ 9,055,000

PDF & Excel (Corporate License)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 생식 유전학 시장 규모는 2025년 91억 달러에 달했습니다. IMARC 그룹은 향후 2034년까지 622억 달러에 달할 전망이며, 2026-2034년 CAGR 23.87%를 나타낼 것으로 예측됩니다. 일반 시민의 유전 질환에 대한 인식 및 이해의 향상, 헬스케어 보급 확대, 출생률의 상승에 수반하는 보조생식기술(ART)의 이용 증가가 생식 유전학 시장 점유율 확대를 견인하는 주요 요인의 일부입니다.

생식 유전학 시장 동향 :

세계 시장은 주로 일반 시민의 유전성 질환에 대한 인식과 이해의 심화에 의해 견인되고 있습니다. 또한 헬스케어의 보급 확대에 따라 미래의 어린이에게 유전성 질환이 발생할 위험을 파악하기 위해 유전자 검사를 받을 예정인 부모의 수가 증가하고 있는 것도 시장을 뒷받침하고 있습니다. 출생률이 증가함에 따라 체외수정(IVF) 및 대리 출산과 같은 보조생식기술(ART)의 사용이 증가하고 있으며, 이는 시장 전망을 양호하게 만듭니다. 이에 따라 차세대 시퀀싱(NGS)이나 고해상도 마이크로어레이 등 선진적 유전자 검사 기술의 지속적인 기술 개발이 시장을 자극하고 있습니다. 또한 여성 출산 연령의 상승에 따라 염색체 이상 발생 위험이 높아지고 있다는 점도 시장을 뒷받침하고 있습니다. 또한 여러 국가의 정부가 유전자 연구 및 검사에 대한 지원을 강화하고 있으며, 이는 시장 성장을 가속하고 있습니다. 또한, 유전체 시퀀싱 검사의 저렴한 가격화가 진행되고, 일반층에 대한 보급이 확대되고 있는 것도 시장을 견인하고 있습니다. 기타 시장 성장 요인으로는 특히 개발도상국에서 소득 수준 상승, 소비자 유전자 검사를 제공하는 조직 증가, 맞춤형 의료 분야의 지속적인 혁신, 광범위한 조사 개발(R&D) 활동 등이 있습니다.

이 보고서에서 답변을 얻을 수 있는 주요 질문

생식 유전학 시장 규모는 어느 정도입니까?
생식 유전학 시장 전망은?
생식 유전학 시장을 견인하는 주요 요인은?

영문목차

The global reproductive genetics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2034, exhibiting a growth rate (CAGR) of 23.87% during 2026-2034. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the reproductive genetics market share.

Reproductive Genetics Market Analysis:

Major Market Drivers: The market for reproductive genetics is driven by increasing awareness of inherited disorders, increasing use of sophisticated genetic testing, and heightened demand for customized fertility therapies. Advanced gene sequencing and diagnostic technologies, along with changing reproductive healthcare infrastructure, are pushing adoption and enhancing access to early diagnosis and intervention solutions.
Key Market Trends: Some of the emerging trends are non-invasive prenatal testing, preimplantation genetic testing, and implementation of artificial intelligence in diagnostics. Personalized reproductive healthcare, growth in genetic counseling services, and emphasis on predictive analytics are transforming the market. Growing partnerships among research centers and clinics further drive innovation and patient-centric reproductive solutions.
Competitive Landscape: The market is marked by competition based on innovation, with companies banking on technology improvement, quality of services, and strategic partnerships. Firms invest their efforts in increasing diagnostic services, precision, and patient experience. Research institutions and health providers are the usual partners in efforts to increase market presence and reach new patient bases.
Challenges and Opportunities: Challenges are presented in the form of ethical issues, regulatory hurdles, and the expense of sophisticated genetic testing. Low awareness in some areas also holds back adoption. Oppositely, opportunities present themselves in creating cost-effective testing options, increasing genetic counseling, and applying AI and machine learning to enhance accuracy, accessibility, and personalized reproductive healthcare outcomes.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Type Insights:

Kits
Laboratory Developed Tests (LDT)
Reagents and Consumables

Procedure Type Insights:

Carrier Screening
Pre-Natal Screening
Pre-Implantation Genetic Testing
Infertility Genetic Testing

Technology Insights:

Next-Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization (ISH/FISH)
Microarray

Application Insights:

Aneuploidy
Structural Chromosomal Abnormality
Single Gene Disorder
Others

Regional Insights:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1.How big is the reproductive genetics market?
2.What is the future outlook of reproductive genetics market?
3.What are the key factors driving the reproductive genetics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Reproductive Genetics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Laboratory Developed Tests (LDT)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Reagents and Consumables
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

7.1 Carrier Screening
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Pre-Natal Screening
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Pre-Implantation Genetic Testing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Infertility Genetic Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Technology

8.1 Next-Generation Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 In Situ Hybridization (ISH/FISH)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Microarray
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Application

9.1 Aneuploidy
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Structural Chromosomal Abnormality
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Single Gene Disorder
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Bangkok Genomics Innovation Public Company Limited
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Centogene N.V.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Fulgent Genetics Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Igenomix (Vitrolife Group)
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Invitae Corporation
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Laboratory Corporation of America Holdings
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 PerkinElmer Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Thermo Fisher Scientific Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio

한글목차

생식 유전학 시장 동향 :

이 보고서에서 답변을 얻을 수 있는 주요 질문

목차

제1장 서문

제2장 조사 범위 및 조사 방법

제3장 주요 요약

제4장 서문

제5장 세계의 생식 유전학 시장

제6장 시장 내역 : 제품 유형별

제7장 시장 내역 : 검사 유형별

제8장 시장 내역 : 기술별

제9장 시장 내역 : 용도별

제10장 시장 내역 : 지역별

제11장 촉진요인 및 억제요인, 기회

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 가격 분석

제15장 경쟁 구도